Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens-Reference-Cited by-同舟云学术

Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens

Published:2019-05 Issue:5 Volume:25 Page:1039-1044
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Maymani Hossein,Lin Paul^ORCID,Saliba Rima M.,Popat Uday,Bashir Qaiser,Shah Nina,Patel Krina,Parmar Simrit,Kebriaei Partow,Hosing Chitra,Ciurea Stefan^ORCID,Andersson Borje,Shpall Elizabeth,Champlin Richard^ORCID,Srour Samer A.,Qazilbash Muzaffar H.^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference35 articles.

1. Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma;Shah;Blood,2015

2. Oral ixazomib, lenalidomide, and dexamethasone for multiple myeloma;Moreau;N Engl J Med,2016

3. Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trials;Nooka;Cancer,2013

4. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial;Durie;Lancet,2017

5. Lenalidomide maintenance after autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis;McCarthy;J Clin Oncol,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years;Frontiers in Oncology;2024-07-31

2. Hematopoietic Cell Transplantation in Multiple Myeloma;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

3. Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern Era;Transplantation and Cellular Therapy;2022-08

4. Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma;Oncology and Therapy;2022-04-04

5. Allogeneic Stem Cell Transplantation in Multiple Myeloma;Cancers;2021-12-23